Use of Dexmedetomidine for Magnetic Resonance Imaging under Sedation in a Pediatric Patient with Phenylketonuria

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Phenylketonuria (PKU) is an inborn error of metabolism caused by a deficiency of the enzyme phenylalanine hydroxylase which results in accumulation of phenylalanine. Patients of PKU presents with seizures, mental retardation, and organ damage and possess a unique challenge to the anesthesiologists when they need anesthetics for diagnostic or surgical procedures. There is limited literature regarding the safety of various anesthetic drugs in PKU patients. None of them reported the use of dexmedetomidine as safer sedative option for such patients. Therefore, we describe the management of such a case posted for magnetic resonance imaging under dexmedetomidine sedation.

References Powered by Scopus

Phenylalanine hydroxylase deficiency: Diagnosis and management guideline

522Citations
N/AReaders
Get full text

High dose dexmedetomidine as the sole sedative for pediatric MRI

274Citations
N/AReaders
Get full text

Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children

120Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Pallavi, K., Mishra, R. K., Goyal, A., Ramesh, V. J., & Patwardhan, P. M. (2022). Use of Dexmedetomidine for Magnetic Resonance Imaging under Sedation in a Pediatric Patient with Phenylketonuria. Journal of Neuroanaesthesiology and Critical Care, 9(1), 35–37. https://doi.org/10.1055/s-0040-1715555

Readers over time

‘21‘23‘2400.751.52.253

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 1

50%

Medicine and Dentistry 1

50%

Save time finding and organizing research with Mendeley

Sign up for free
0